Boston Scientific Receives U.S. FDA Approval for the Vercise™ Deep Brain Stimulation System

Share

(December 11, 2017) - Boston Scientific Corporation today announced that it has received approval from the U.S. Food and Drug Administration for the Vercise™ Deep Brain Stimulation System. The platform offers physicians advanced technology to treat symptoms of Parkinson’s disease. Read more

Click for a printer friendly version

Back to top